Enhance MD vs Hers: Semaglutide from $49 vs Wegovy
Looking for a direct comparison between Enhance MD vs Hers for GLP-1 weight-loss options? Quick verdict: Enhance MD is focused on low introductory pricing for compounded semaglutide and tirzepatide, while Hers centers on FDA-approved Wegovy and branded options with an ongoing membership requirement.
Start Enhance MD semaglutide from $49
How these two providers differ at a glance
This comparison contrasts Enhance MD and Hers across pricing, medication types, regulatory status, pricing model, and membership or access requirements. Every statement below follows the supplied source details for each provider.
Distinctive differences we will use to compare
- Starting price and introductory offers
- Medication type and FDA approval status
- Pricing model and dose escalation policy
- Membership and access requirements
- Platform scope: multiple compounds vs brand-name focus
Pricing: starting cost and ongoing structure
Enhance MD advertises semaglutide starting at $49 for the first month and tirzepatide starting at $99 for the first month. Those are introductory first-month prices; ongoing flat-rate prices are higher and are described as a single price that stays the same at every dose. Hers lists Wegovy from $149/month for the medication portion, but medication is only available with an active Hers Weight Loss Membership which has a first month fee of $39 and auto-renews at $149/month thereafter. The Hers pricing notes that total cost includes membership plus medication and that membership is required.
Explore Hers Wegovy plans from $149/mo
Medication types and regulatory status
Enhance MD offers compounded semaglutide and compounded tirzepatide on the same platform. The source explicitly notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved Wegovy, a brand-name semaglutide product, and emphasizes that it does not offer compounded medications. The Hers source also highlights other brand-name GLP-1s and states Ozempic and Wegovy are registered trademarks of Novo Nordisk, and Zepbound is a registered trademark of Eli Lilly.
See Enhance MD compound options
Access, membership, and clinician oversight
Enhance MD operates as a licensed telehealth platform with clinician-directed review and has treated more than 10,000 patients, according to the source. It does not bill insurance and uses a direct-pay model. Hers requires an active membership for medication access and states that a prescription is not guaranteed; membership and medication are billed separately. Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate.
Pricing model, dose escalation, and predictability
Enhance MD highlights flat-rate pricing that stays the same at every dose, which it presents as avoiding fee escalation during titration. The source frames this as a budgeting advantage versus competitors that increase fees at higher doses. Hers emphasizes name-brand medications with no price markups but includes a membership model that affects total monthly cost and availability.
Side-by-side comparison table
| Criteria | Enhance MD | Hers |
|---|---|---|
| Starting price (first month) | Semaglutide from $49; Tirzepatide from $99 | Wegovy from $149/mo; injectable from $199/mo (medication only) |
| Medication types | Compounded semaglutide and tirzepatide on one platform | FDA-approved Wegovy and other brand-name GLP-1s, no compounded meds |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA | Offers FDA-approved Wegovy; trademarks noted |
| Pricing model | Flat-rate pricing that stays the same at every dose after introductory period | Medication price plus required membership fee; membership auto-renews |
| Membership required | No membership required; direct-pay model | Yes. Active Hers Weight Loss Membership required for medication |
| Platform scope | Both semaglutide and tirzepatide available | Brand-name GLP-1 focus including Wegovy and other options |
Patient considerations and tradeoffs
If first-month cost is the primary concern, the source shows Enhance MD has lower introductory prices for both semaglutide and tirzepatide. If using an FDA-approved branded product is essential, Hers supplies Wegovy and emphasizes branded options with ongoing care teams and dose check-ins. Enhance MD notes a large treated-patient base and flat-rate dose pricing but also reminds users that its medications are compounded and not FDA-approved finished products.
Compare Hers membership and medication details
Conclusion: Choose based on priorities
Enhance MD vs Hers comes down to two clear tradeoffs from the supplied sources. Choose Enhance MD if you prioritize the lowest first-month pricing and access to both compounded semaglutide and tirzepatide on one platform with flat-rate dosing. Choose Hers if you require an FDA-approved brand-name option like Wegovy and accept a membership model that governs access and total monthly cost.